INFU - AMEX
InfuSystem Holdings, Inc.
$9.03
+0.67%InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
At a Glance
Live SnapshotInfuSystem Holdings, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Effective Tax Rate
Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
InfuSystem Holdings, Inc. Income Statement
INFU • AMEX
| InfuSystem Holdings, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
143.4M | 134.9M | 125.8M | 109.9M | 102.4M | 97.4M | 81.1M | 67.1M | 71.1M | 70.5M | 72.1M | 66.5M | 62.3M | 58.8M | 54.6M | 47.2M | 39M | 35.4M | 6.6M | 0.0 | |
GROSS PROFIT | ||||||||||||||||||||
(63.1M) | (64.5M) | (62.7M) | (49.4M) | (43.8M) | (38.6M) | (34.2M) | (28.1M) | (27.7M) | (25.8M) | (20.9M) | (19.1M) | (18.6M) | (15.9M) | (19.3M) | (13.7M) | (10.3M) | (9.2M) | (1.6M) | (0.0) | |
80.3M | 70.4M | 63.1M | 60.6M | 58.5M | 58.8M | 46.9M | 39M | 43.4M | 44.7M | 51.2M | 47.4M | 43.7M | 42.9M | 35.4M | 33.5M | 28.6M | 26.2M | 5M | 0.0 | |
OPERATING INCOME | ||||||||||||||||||||
(68.4M) | (63.5M) | (59M) | (58.9M) | (55.7M) | (49.9M) | (43.4M) | (38.6M) | (46.2M) | (43.8M) | (42.3M) | (38M) | (37.8M) | (40.9M) | (34.1M) | (34.5M) | (23.3M) | (21.4M) | (6.5M) | (20.8M) | |
(67.5M) | (62.5M) | (58M) | (56.4M) | (51.5M) | (44.9M) | (38.9M) | (34M) | (35M) | (34.3M) | (34.2M) | (29.7M) | (28.6M) | (32.9M) | (27.4M) | (27.7M) | (17.5M) | (16.4M) | (6.1M) | (20.8M) | |
11.9M | 6.9M | 4.1M | 1.7M | 2.8M | 8.8M | 3.5M | 415K | -3.8M | 974K | 8.9M | 9.3M | 5.9M | 2M | -66.4M | -938K | 5.3M | 4.8M | -1.5M | -20.8M | |
PRE-TAX INCOME | ||||||||||||||||||||
(1.3M) | (1.8M) | (2.2M) | (1.4M) | (1.4M) | (1.3M) | (1.9M) | (1.4M) | (1.3M) | (1.3M) | (1.7M) | (3.1M) | (3.5M) | (3.3M) | (2.2M) | (3.4M) | (3.5M) | (3.8M) | (774K) | (1.3K) | |
-1.3M | -1.8M | -2.2M | -1.4M | -1.4M | -1.3M | -1.9M | -1.4M | -1.3M | -1.3M | -1.7M | -3.1M | -3.5M | -3.3M | -2.2M | -3.4M | -3.5M | -3.7M | 3.1M | 3.2M | |
(920K) | (991K) | (990K) | (2.5M) | (4.3M) | (5.1M) | (4.4M) | -37K | -113K | (6K) | (13K) | (13K) | (301K) | -141K | (6.8M) | (6.8M) | (5.8M) | (5M) | (6.5M) | (0.0) | |
-1.3M | -1.8M | -2.2M | -1.5M | -1.6M | -1.3M | -2M | -1.5M | -1.4M | -1.3M | -3.3M | -3.1M | -3.2M | -4.2M | -2.2M | -2.3M | -3.6M | 6.1M | -189K | -6,821.4B | |
10.6M | 5.1M | 1.9M | 130K | 1.3M | 7.5M | 1.5M | -1M | -5.3M | -364K | 5.6M | 6.2M | 2.7M | -2.2M | -68.6M | -3.2M | 1.8M | 10.9M | -1.7M | -6.8M | |
NET INCOME | ||||||||||||||||||||
-4M | (2.7M) | (979K) | (112K) | -163K | -9.8M | (163K) | (53K) | (15.5M) | -142K | (1.8M) | (2.9M) | (1M) | -663K | -23.1M | -1.4M | (977K) | (907K) | (1.1M) | (1M) | |
6.6M | 2.3M | 872K | 18K | 1.4M | 17.3M | 1.4M | -1.1M | -20.7M | -222K | 3.7M | 3.4M | 1.7M | -1.5M | -45.4M | -1.9M | 774K | 10M | -2.8M | -7.9M |
SEC Filings
INFU - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 18, 2026 | May 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 14, 2026 | May 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 12, 2026 | May 11, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 10, 2026 | April 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 19, 2026 | March 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 27, 2026 | February 27, 2026 | 2026 |
Related Guides
Continue your INFU research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.